These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
463 related items for PubMed ID: 19383775
1. Hypoglycemia from IGF2 overexpression associated with activation of fetal promoters and loss of imprinting in a metastatic hemangiopericytoma. Lawson EA, Zhang X, Crocker JT, Wang WL, Klibanski A. J Clin Endocrinol Metab; 2009 Jul; 94(7):2226-31. PubMed ID: 19383775 [Abstract] [Full Text] [Related]
2. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor. Yballe CM, Vu TH, Hoffman AR. J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375 [Abstract] [Full Text] [Related]
3. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekström TJ. Oncogene; 1995 Jul 20; 11(2):221-9. PubMed ID: 7624139 [Abstract] [Full Text] [Related]
4. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues. Ulaner GA, Yang Y, Hu JF, Li T, Vu TH, Hoffman AR. Endocrinology; 2003 Oct 20; 144(10):4420-6. PubMed ID: 12960026 [Abstract] [Full Text] [Related]
5. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Constância M, Dean W, Lopes S, Moore T, Kelsey G, Reik W. Nat Genet; 2000 Oct 20; 26(2):203-6. PubMed ID: 11017078 [Abstract] [Full Text] [Related]
6. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis. Vernucci M, Cerrato F, Besnard N, Casola S, Pedone PV, Bruni CB, Riccio A. Oncogene; 2000 Dec 14; 19(54):6376-85. PubMed ID: 11175353 [Abstract] [Full Text] [Related]
7. Genetic imprinting of H19 and IGF2 in domestic pigs (Sus scrofa). Li C, Bin Y, Curchoe C, Yang L, Feng D, Jiang Q, O'Neill M, Tian XC, Zhang S. Anim Biotechnol; 2008 Dec 14; 19(1):22-7. PubMed ID: 18228173 [Abstract] [Full Text] [Related]
8. A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate. Dobosy JR, Fu VX, Desotelle JA, Srinivasan R, Kenowski ML, Almassi N, Weindruch R, Svaren J, Jarrard DF. Prostate; 2008 Aug 01; 68(11):1187-95. PubMed ID: 18459101 [Abstract] [Full Text] [Related]
9. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases. Kim SJ, Park SE, Lee C, Lee SY, Kim IH, An HJ, Oh YK. Gynecol Oncol; 2003 Mar 01; 88(3):411-8. PubMed ID: 12648595 [Abstract] [Full Text] [Related]
10. [VIGILIN involves in regulation of imprinting gene IGF2 and H19 in human hepatocellular carcinoma cell]. Ge YJ, Xie XY, Yang B, Chai XJ, Zhang YC, Qin Y. Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep 01; 40(5):770-4. PubMed ID: 19950580 [Abstract] [Full Text] [Related]
11. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP. Nat Genet; 1994 Jul 01; 7(3):433-9. PubMed ID: 7920665 [Abstract] [Full Text] [Related]
12. Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction. Tabano S, Colapietro P, Cetin I, Grati FR, Zanutto S, Mandò C, Antonazzo P, Pileri P, Rossella F, Larizza L, Sirchia SM, Miozzo M. Epigenetics; 2010 May 16; 5(4):313-24. PubMed ID: 20418667 [Abstract] [Full Text] [Related]
13. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II. Kim SJ, Park SE, Lee C, Lee SY, Jo JH, Kim JM, Oh YK. Biochim Biophys Acta; 2002 Apr 24; 1586(3):307-15. PubMed ID: 11997082 [Abstract] [Full Text] [Related]
14. Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2. Braunschweig MH, Owczarek-Lipska M, Stahlberger-Saitbekova N. BMC Genet; 2011 May 17; 12():47. PubMed ID: 21575277 [Abstract] [Full Text] [Related]
15. Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression. Dejeux E, Olaso R, Dousset B, Audebourg A, Gut IG, Terris B, Tost J. Endocr Relat Cancer; 2009 Sep 17; 16(3):939-52. PubMed ID: 19502451 [Abstract] [Full Text] [Related]
16. Regulatory mechanisms at the mouse Igf2/H19 locus. Kaffer CR, Grinberg A, Pfeifer K. Mol Cell Biol; 2001 Dec 17; 21(23):8189-96. PubMed ID: 11689707 [Abstract] [Full Text] [Related]
17. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression. Wilkin F, Gagné N, Paquette J, Oligny LL, Deal C. J Clin Endocrinol Metab; 2000 May 17; 85(5):2048-56. PubMed ID: 10843195 [Abstract] [Full Text] [Related]
18. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma]. Wu J, Qin Y, Li B, He WZ, Sun ZL. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan 17; 38(1):49-52. PubMed ID: 17294726 [Abstract] [Full Text] [Related]
19. The 3' portion of the mouse H19 Imprinting-Control Region is required for proper tissue-specific expression of the Igf2 gene. Hagège H, Nasser R, Weber M, Milligan L, Aptel N, Jacquet C, Drewell RA, Dandolo L, Surani MA, Cathala G, Forné T. Cytogenet Genome Res; 2006 Jan 17; 113(1-4):230-7. PubMed ID: 16575185 [Abstract] [Full Text] [Related]
20. Analysis of imprinted IGF2/H19 gene methylation and expression in normal fertilized and parthenogenetic embryonic stem cells of pigs. Uh KJ, Park CH, Choi KH, Park JK, Jeong YW, Roh S, Hyun SH, Shin T, Lee CK, Hwang WS. Anim Reprod Sci; 2014 Jun 10; 147(1-2):47-55. PubMed ID: 24794444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]